Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 8Sarcoma 1Other hematologic neoplasm 1NET 1Endocrine 1Breast 1

Conditions

Thyroid Neoplasms 6Neuroendocrine Tumors 5Urinary Bladder Neoplasms 3Thyroid Cancer, Papillary 3Sarcoma 3Cholangiocarcinoma 3Carcinoma, Hepatocellular 3Breast Neoplasms 3Adenocarcinoma, Follicular 3Uterine Cervical Neoplasms 2Testicular Neoplasms 2Stomach Neoplasms 2Pheochromocytoma 2Paraganglioma 2Ovarian Neoplasms 2Carcinoma, Transitional Cell 2Carcinoma, Neuroendocrine 2Brain Neoplasms 2Adrenal Gland Neoplasms 2Vaginal Neoplasms 1Uveal Melanoma 1Uterine Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thymus Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Solitary Fibrous Tumors 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Salivary Gland Neoplasms 1Prostatic Neoplasms 1

Interventions

romidepsin 1ganitumab 1conatumumab 1amino-acid, glucose, and electrolyte solution 1Lactones 1Fluorodeoxyglucose F18 1Depsipeptides 1Bevacizumab 190Y-octreotide, DOTA-Tyr(3)- 1177Lu-octreotide, DOTA(0)-Tyr(3)- 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma × Fluorodeoxyglucose F18 × Endocrine × Clear all
NCT05396118 2024-05-14

Simultaneous Hyperpolarized [1-13C]Pyruvate and 18F-FDG PET/MRS in Cancer Patients

Rigshospitalet, Denmark

Phase 2 Unknown
15 enrolled
BreastEndocrineLymphoidNETSarcoma

Breast Neoplasms, Lymphoma, Sarcoma, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡